Page last updated: 2024-08-23

epirubicin and Uveal Neoplasms

epirubicin has been researched along with Uveal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorval, T; Lantz, O; Louis, D; Milder, M; Péguillet, I; Piperno-Neumann, S; Scholl, SM; Vincent-Salomon, A1

Other Studies

1 other study(ies) available for epirubicin and Uveal Neoplasms

ArticleYear
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
    Cancer research, 2014, Apr-15, Volume: 74, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Lymphocytes; Cell Differentiation; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Leukapheresis; Melanoma; Neoadjuvant Therapy; T-Lymphocyte Subsets; Taxoids; Uveal Neoplasms

2014